FIVE-AND-SIX-MEMBERED HETEROCYCLIC COMPOUND, AND PREPARATION METHOD, PHARMACEUTICAL COMPOSITION AND USE THEREOF

(19)

(11)

EP 2 947 084 B8

(12)	CORRECTED EUROPEAN PATENT SPECIFICATION
	Note: Bibliography reflects the latest situation

(15)	Correction information:
	Corrected version no 1 (W1 B1)

(48)	Corrigendum issued on:
	10.03.2021 Bulletin 2021/10

(45)	Mention of the grant of the patent:
	23.09.2020 Bulletin 2020/39

(21)	Application number: 14740886.8

(22)	Date of filing: 17.01.2014

(51)

International Patent Classification (IPC):

C07D 495/00^(2006.01)
C07D 487/04^(2006.01)
A61P 35/00^(2006.01)

C07D 491/048^(2006.01)
A61K 31/519^(2006.01)

(86)	International application number:
	PCT/CN2014/070778

(87)	International publication number:
	WO 2014/111037 (24.07.2014 Gazette 2014/30)

(54)

FIVE-AND-SIX-MEMBERED HETEROCYCLIC COMPOUND, AND PREPARATION METHOD, PHARMACEUTICAL COMPOSITION AND USE THEREOF

FÜNF- ODER SECHSENDIGE HETEROCYCLISCHE VERBINDUNG UND HERSTELLUNGSVERFAHREN, PHARMAZEUTISCHE ZUSAMMENSETZUNG UND VERWENDUNG DAVON

COMPOSÉ HÉTÉROCYCLIQUE À CINQ ET SIX CHAÎNONS, PROCÉDÉ DE PRÉPARATION, COMPOSITION PHARMACEUTIQUE ET APPLICATION ASSOCIÉS

(84)	Designated Contracting States:
	AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

(30)

Priority:

18.01.2013 CN 201310019856

(43)	Date of publication of application:
	25.11.2015 Bulletin 2015/48

(73)	Proprietor: Guangzhou Maxinovel Pharmaceuticals Co., Ltd.
	Sino-Singapore Guangzhou Knowledge Center Guangzhou 510555 (CN)

(72)	Inventors:
	XU, Zusheng Shanghai 201203 (CN) ZHANG, Nong Shanghai 201203 (CN) SUN, Qingrui Shanghai 201203 (CN) WANG, Tinghan Shanghai 201203 (CN)

(74)	Representative: Gulde & Partner
	Patent- und Rechtsanwaltskanzlei mbB Wallstraße 58/59 10179 Berlin 10179 Berlin (DE)

(56)

References cited: :

WO-A1-2009/049743
CN-A- 101 405 289
CN-A- 102 307 875

WO-A1-2010/090764
CN-A- 101 679 440
CN-A- 102 762 571

Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).